Actively Recruiting

Phase Not Applicable
Age: 18Years - 70Years
All Genders
ID04678635

Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies

Led by University of Sao Paulo · Updated on 2024-12-09

40

Participants Needed

1

Research Sites

30 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Systemic autoimmune myopathies are rheumatic diseases affecting the striated skeletal muscles, including types such as polymyositis, dermatomyositis, and immune-mediated necrotizing myopathy. These diseases often cause significant muscle weakness and disability, despite improvements in pharmacological treatments. Researchers are evaluating the safety and effectiveness of chronic transcranial direct current stimulation combined with aerobic exercises in people with these myopathies through a prospective, randomized, double-blind, placebo-controlled study. Participants are assigned to one of two groups: one receives transcranial direct current stimulation while performing aerobic exercises, and the other performs aerobic exercises alone without stimulation. The stimulation involves applying a mild electrical current of 2mA through electrodes placed on the head over the primary motor cortex for 20 minutes during the exercise session. Each participant completes a total of 10 sessions. During the study, researchers monitor safety by tracking treatment-emergent adverse events before, immediately after, and at multiple points up to 300 days following the last stimulation session. Muscle disease activity, muscle enzyme levels, physical function, fatigue, pain, and global activity are assessed at the same intervals using various scales and physical tests. This comprehensive monitoring aims to evaluate both safety and potential benefits over time for up to nearly a year after treatment.

CONDITIONS

Brief Title

Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies

Who Can Participate

Age: 18Years - 70Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Meet classification criteria according to EULAR/ACR 2017
  • Meet classification criteria according to Connors et al.
Not Eligible

You will not qualify if you...

  • Have neoplasia (cancer)
  • Use a heart pacemaker
  • Have metallic clips inside the body
  • Have infections such as HIV, HTLV-1, Hepatitis
  • Are pregnant
  • Have a history of seizures or epilepsy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Duration of 10 sessions

Participants receive 10 sessions of transcranial direct current stimulation combined with aerobic exercises or sham stimulation with aerobic exercises.

10 visits (in-person)

Follow-up

Duration - Up to 300 days after last stimulation session

Participants are monitored for safety and efficacy up to 300 days after the last stimulation session.

Visits at immediate, 30, 60, 90, and 300 days after last session

Trial Site Locations

Total: 1 location

1

Samuel K Shinjo

São Paulo, São Paulo, Brazil

Actively Recruiting

Loading map...

Research Team

S

Samuel K Shinjo, PhD

S

Sao Paulo University

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Similar Trials

Characterization of Familial Myopathy and Paget Disease of B...

Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Impact of Transcranial Direct Current Stimulation in Pain, Fatigue, and Health Quality of Life of Patients with Idiopathic Inflammatory Myopathies: A Randomized, Double-Blind, Sham-Controlled Crossover Clinical Trial.

Rafael Giovani Missé, Alexandre Moura Dos Santos, Isabela Bruna Pires Borges...

https://pubmed.ncbi.nlm.nih.gov/38332984